According to Future Market Insights, the global nephroblastoma therapeutics industry size is projected to rise at a steady growth valued at US$ 2.12 billion in 2023, with a 9.88% CAGR until 2033, being valued at US$ 5.44 billion. The important factors that are compelling the growth of the revenue of the nephroblastoma therapeutics market are …